Pacific Edge Limited (“PEB”) – Trading Halt of Securities

NZX Limited
Level 2, NZX Centre
11 Cable Street
PO Box 2959
Wellington 6140
New Zealand
Tel +64 4 472 7599

www.nzx.com

Memorandum

To:
Market Participants
From:
NZX Product Operations
Date:
Friday, 10 January 2025
Subject
: Pacific Edge Limited (“PEB”) – Trading Halt of Securities


Message
:

NZ RegCo advises that, at the request of the Pacific Edge Limited (“PEB”), it has placed a
trading halt on PEB ordinary shares. The trading halt was applied at pre-market open today,
Friday, 10 January 2025.
Attached is the trading halt application, for further information.
Please contact NZX Product Operations on +64 4 496 2853 or productoperations@nzx.com
with any queries.

ENDS

---

10 January 2025
ASX Limited
20 Bridge St
Sydney NSW 2000
Australia
NZ RegCo
11 Cable St
Wellington
New Zealand
Request for trading halt: PACIFIC EDGE LIMITED (ASX Code: PEB, NZX Code: PEB)
We request a trading halt to be applied to our securities: (ISIN: NZPEBE0002S1) under ASX Listing
Rule 17.1 and NZX Listing Rule 9.9.1(a) and set out below details of the request as per the rules of
each of ASX and NZX.
We would like the trading halt to commence from:the commencement of trading on the ASX and
NZX today (10 January 2025) ahead of the market open.
Reasons for trading halt:The company is aware Novitas, the Medicare Administrative Contractor with
laboratory, has finalized the draft Local Coverage Determination
under a new title
Specific Tests39365) covering the reimbursement of Cxbladder tests by Medicare.
Pacific Edge is currently reviewing the LCD and the associated documentation and needs time to
assess the implications of the announcement, consult with US legal advisers and industry partners, and
prepare and announcement that provides context to investors.
It expects to provide an update to the market ahead of the opening of trading on Monday 13 January
2025.
How long we want the trading halt to last: until the opening of trading on the NZX and ASX on
Monday 13 January 2025.
The event we expect to happen that will end the trading halt: The release of a statement to the
market before the market open.
Other information necessary to inform the market about the trading halt or that ASX or NZ RegCo
have requested: see the statement below on the information in the market memorandum to be
released in relation to the trading halt.
Information to include in any market memorandum relating to the halt:
Pacific Edge is aware Novitas, the Medicare Administrative Contractor with jurisdiction for the

under a new title
covering the reimbursement of its Cxbladder tests by Medicare.
reviews the LCD and the associated documentation.
The determination covers significant new information and Pacific Edge needs time to assess the
implications of the announcement, consult with US legal advisers and industry partners, and prepare
an announcement that provides context to investors.
Pacific Edge is currently reviewing the information and expects to provide an update to the market
ahead of the opening of trading on Monday 13 January 2025 and expects the trading halt to be lifted at
that time.
In the meantime, the company is not in a position to make any further comment.
We confirm that we are not aware of any reason why the trading halt should not be granted.

Yours sincerely


Grant Gibson
Chief Financial Officer
Pacific Edge Limited

designated Listings Compliance Adviser and the relevant general trading halt email address at ASX:
tradinghaltssydney@asx.com.au, tradinghaltsmelbourne@asx.com.au or
tradinghaltsperth@asx.com.au